Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders |
Mechanism BCL6 degraders(B-cell lymphoma 6 protein degraders) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Hodgkin's lymphoma refractory | Phase 1 | China | 28 Aug 2025 | |
| Lymphoma | IND Approval | United States | 01 Sep 2025 | |
| Diffuse Large B-Cell Lymphoma | Preclinical | China | 27 Apr 2025 |





